The New York Times is releasing a series of data files with cumulative counts of coronavirus cases in the United States, at the state and county level, over time. We are compiling this time series data from state and local governments and health departments in an attempt to provide a complete record of the ongoing outbreak.

Since late January, The Times has tracked cases of coronavirus in real time as they were identified after testing. Because of the widespread shortage of testing, however, the data is necessarily limited in the picture it presents of the outbreak.

We have used this data to power our maps and reporting tracking the outbreak, and it is now being made available to the public in response to requests from researchers, scientists and government officials who would like access to the data to better understand the outbreak.

The data begins with the first reported coronavirus case in Washington State on Jan. 21, 2020. We will publish regular updates to the data in this repository.

The COVID Tracking Project collects information from 50 US states, the District of Columbia, and 5 other US territories to provide the most comprehensive testing data we can collect for the novel coronavirus, SARS-CoV-2. We attempt to include positive and negative results, pending tests, and total people tested for each state or district currently reporting that data.

Testing is a crucial part of any public health response, and sharing test data is essential to understanding this outbreak. The CDC is currently not publishing complete testing data, so we’re doing our best to collect it from each state and provide it to the public. The information is patchy and inconsistent, so we’re being transparent about what we find and how we handle it—the spreadsheet includes our live comments about changing data and how we’re working with incomplete information.

From here, you can also learn about our methodology, see who makes this, and find out what information states provide and how we handle it.

The COVID-19 dashboard includes data on city/town COVID-19 activity, confirmed and probable cases of COVID-19, confirmed and probable deaths related to COVID-19, and the demographic characteristics of cases and deaths.

NOTE: This dataset is no longer updated as of 1/31/2024. Please use COVID-19 Treatments. Locations of publicly available COVID-19 Therapeutics. Dataset only includes locations for Paxlovid (oral antiviral), Lagevrio (oral antiviral), and outpatient Veklury (intravenous antiviral infusion). COVID-19 therapeutics require a prescription to obtain. Limitations: public contact information. To filter, click 'View Data' below, then 'Filter.' To save your view, click 'Save as,' and this configuration will be saved in your profile under 'My Assets.' Please try not to publish dataset publicly, unless necessary. On 1/3/2022 - The following changes were made to this dataset. - Dropped the Expected Deliver Date column - This was a derived field set to 3 days after the Last Order Date field. - Added the following fields Last Date Delivered Total Courses Courses Available Courses Available Date On 1/4/2022 - Added Geocoded Address On 1/11/2022 - Added NPI - National Provider Identifier On 2/18/2022 - Added new therapeutics, Bebtelovimab & Sotrovimab. On 3/16/2022 - Dropped the following columns - last_order_date - last_date_delivered - total_courses - courses_available_date Added the following columns - facility_id - last_report_date - grantee_code - provider_pin - state_provider_pin On 3/31/2022 - Dropped the following columns - facility_id - grantee_code - provider_pin - state_provider_pin Added the following columns - provider_status - provider_note

NOTE: As of 12/17/2024, this dataset is no longer updated. Please use ASPR Treatments Locator. This dataset displays pharmacies, clinics, and other locations with safe and effective COVID-19 medications. These medications require a prescription from a healthcare provider. Some locations, known as Test to Treat sites, give you the option to get tested, get assessed by a healthcare provider, and receive treatment – all in one visit. COVID-19 medications may be available at additional locations that are not shown in this dataset. The locations displayed have either self-attested they have inventory of Paxlovid (nirmatrelvir packaged with ritonavir), Lagevrio (molnupiravir), or Veklury (Remdesivir) within at least the last two months and/or reported participation in the Paxlovid Patient Assistance Program. Sites that have not reported in the last two weeks display a notification, "Inventory has not been reported in the last 2 weeks. Please contact the provider to make sure the product is available." Outpatient COVID-19 medications may be available at additional locations not listed on this website. All therapeutics identified in the locator not approved by the FDA must be used in alignment with the terms of the respective product’s Emergency Use Authorization. Visit COVID-19 Treatments and Therapeutics for more information on all treatment options. This website identifies sites that have commercially purchased inventory of COVID-19 treatments and, in some cases, may identify sites that have remaining, no-cost U.S. government distributed supply. Some sites may charge for services not covered by insurance. Some sites may offer telehealth services. This website is intended for informational purposes only and does not serve as an endorsement or recommendation for use of any of the locations listed on the sites. Clarification for DoD Facilities: Those individuals eligible for care in an MTF include Active Duty Service Members (ADSMs), covered beneficiaries enrolled in TRICARE Prime or Select, including TRICARE Reserve Select (TRS), TRICARE Retired Reserve (TRR) and TRICARE Young Adult (TYA) participants, TRICARE for Life beneficiaries, and individuals otherwise entitled by law to MTF care (e.g., regular retired members and their dependents who are not enrolled in TRICARE but who are otherwise eligible for MTF space-available care, certain foreign military members and their families registered in DEERS, and others).

COVID-19 testing sites in the District of Columbia. Individuals are encouraged to get tested through their own health care provider so that when the test results come back the patient is already connected to the health care they need. If an individual needs a COVID-19 test and they do not have a provider, there are a number of options to obtain a test and a provider. If an individual needs a test and their provider is unable to give them a test, that individual should come to one of the District’s walk-up or drive-thru sites. More information at https://coronavirus.dc.gov/testing.

This view is a copy of the original COVID-19 Testing Locations in the United States - public dataset (https://giscorps.maps.arcgis.com/home/item.html?id=d7d10caf1cec43e0985cc90fbbcf91cb). The parent hosted feature service is the same. This version is symbolized by site status.This feature layer view contains information about COVID-19 screening and testing locations. It is made available to the public using the GISCorps COVID-19 Testing Site Locator app (https://giscorps.maps.arcgis.com/apps/webappviewer/index.html?id=2ec47819f57c40598a4eaf45bf9e0d16) and on findcovidtesting.com. States and counties are encouraged to include this feature service in their own testing site locator apps as well.Please submit new testing sites or updated testing site information via this form: https://arcg.is/10S1ib. Including this link on your organization's testing site finder web app will allow testing providers to add their own sites directly to the map, improving the accuracy and completeness of the dataset. GISCorps volunteers verify each submission prior to including it in this public view. You can also add your sites in bulk by completing a copy of this template and emailing it to admin@giscorps.org. This dataset is updated daily. All information is sourced from public information shared by health departments, local governments, and healthcare providers. The data are aggregated by GISCorps volunteers in collaboration with volunteers from Coders Against COVID and should not be considered complete or authoritative. Please contact testing sites or your local health department directly for official information and testing requirements.The objective of this application is to aggregate and facilitate the public communications of local governments, health departments, and healthcare providers with regard to testing site locations. GISCorps does not share any screening or testing site location information not previously made public or provided to us by one of those entities.Latest Arcade code for popups available here: https://docs.google.com/document/d/1PDOq-CxUX9fuC2v3N8muuuxN5mLMinWdf7fiwUt1lOM/edit?usp=sharing

After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic. Data about COVID-19 will continue to be updated at CDC’s COVID Data Tracker.

The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.

It is a weekly snapshot in time that:

• Focuses on recent outcomes in the last seven days and changes relative to the month prior
• Provides additional contextual information at the county level for each state, and includes national level information
• Supports rapid visual interpretation of results with color thresholds

Business Analyst Report Template. This infographic contains data provided by American Community Survey (ACS), Esri, Esri and Infogroup. The vintage of the data is 2013-2017, 2019, 2024.

An application used by the public to locate the nearest Coronavirus testing or screening location. Read more about this project here: https://covid-19-giscorps.hub.arcgis.com/pages/contribute-covid-19-testing-sites-dataAbout the app:The GISCorps Testing Sites Locator can be used by the general public to locate screening and testing sites in the community and obtain instructional information and operational hours. The objective of this application is to aggregate and facilitate the public communications of local governments, health departments, and healthcare providers. GISCorps does not share any screening or testing site location information not previously made public by one of those entities.Adjust the slider to the desired buffer distance. Search for an address or place in the search bar, or click a location directly on the map to define the location to be buffered. Click a layer in the list of results and click the facility you are interested in. Select the Directions tab to view driving directions to the facility from the defined location.To submit updated information for one of our testing sites or to suggest a new one, please fill out and submit this form. To access our public feature service, click here. GISCorps can also provide a spreadsheet template for bulk data uploads; please contact us at info@giscorps.org to find out more about that option.All information is sourced from the websites of local governments and healthcare providers by volunteers from GISCorps and Coders Against COVID and is not complete or authoritative. Please contact testing sites or your local health department directly for official information and testing requirements. If you are experiencing extreme COVID-19 symptoms such as trouble breathing, please seek medical attention immediately.

This dataset tracks the updates made on the dataset "COVID-19 Public Therapeutic Locator" as a repository for previous versions of the data and metadata.

Locations of publicly available COVID-19 Therapeutics.

Locations of publicly available COVID-19 Therapeutics. Dataset only includes locations for Evusheld (monoclonal antibody), Molnupiravir (antiviral), and Paxlovid (Antiviral). COVID-19 therapeutics require a prescription to obtain.

Read about this volunteer-driven effort, access data and apps, and contribute your own testing site data:https://covid-19-giscorps.hub.arcgis.com/pages/contribute-covid-19-testing-sites-dataItem details page:https://giscorps.maps.arcgis.com/home/item.html?id=d7d10caf1cec43e0985cc90fbbcf91cbThis view is the originalCOVID-19 Testing Locations in the United States - public dataset. A backup copy also exists:https://giscorps.maps.arcgis.com/home/item.html?id=11fe8f374c344549815a716c8472832f. The parent hosted feature service is the same.This version is symbolized by type of test (molecular, antibody, antigen, or combinations thereof).This feature layer view contains information about COVID-19 screening and testing locations. It is made available to the public using the GISCorps COVID-19 Testing Site Locator app (https://giscorps.maps.arcgis.com/apps/webappviewer/index.html?id=2ec47819f57c40598a4eaf45bf9e0d16) and onfindcovidtesting.com. States and counties are encouraged to include this feature service in their own testing site locator apps as well.Please submit new testing sites or updated testing site information via this form:https://arcg.is/10S1ib. Including this link on your organization's testing site finder web app will allow testing providers to add their own sites directly to the map, improving the accuracy and completeness of the dataset.GISCorps volunteers verify each submission prior to including it in this public view. You can also add your sites in bulk by completing a copy ofthis templateand emailing it to admin@giscorps.org.This dataset is updated daily. All information is sourced from public information shared by health departments, local governments, and healthcare providers. The data are aggregated byGISCorps volunteers in collaboration with volunteers from Coders Against COVID and should not be considered complete or authoritative. Please contact testing sites or your local health department directly for official information and testing requirements.The objective of this application is to aggregate and facilitate the public communications of local governments, health departments, and healthcare providers with regard to testing site locations. GISCorps does not share any screening or testing site location information not previously made public or provided to us by one of those entities.Data dictionary document:https://docs.google.com/document/d/1HlFmtsT3GzibixPR_QJiGqGOuia9r-exN3i5UK8c6h4/edit?usp=sharingArcade code for popups:https://docs.google.com/document/d/1PDOq-CxUX9fuC2v3N8muuuxN5mLMinWdf7fiwUt1lOM/edit?usp=sharing

A. SUMMARY A list of testing locations including address and coordinates for mapping.

B. HOW THE DATASET IS CREATED Dataset is manually compiled by staff from the various testing providers.

C. UPDATE PROCESS Data is updated as needed. If you have a site you'd like added to the dataset and map, please email DPH.DOC.Ops.Testing@sfdph.org.

D. HOW TO USE THIS DATASET Dataset can be used to map locations of test sites and understand which require insurance and which do not. It is the base data used to power the user-facing map of testing locations at https://datasf.org/covid19-testing-locations

View daily updates and historical trends for Maine Coronavirus Full Vaccination Rate. Source: Our World in Data. Track economic data with YCharts analytic…

ASPR Treatments Locator

Outpatient COVID-19 and influenza (flu) medications may be available at additional locations not listed on this dataset. The locations displayed have either self-attested they have inventory of COVID-19 or influenza antiviral medications within at least the last two months and/or reported participation in the Paxlovid Patient Assistance Program.

All therapeutics identified in the locator not approved by the FDA must be used in alignment with the terms of the respective product’s Emergency Use Authorization. Visit the ASPR COVID-19 Treatments page for more information on all COVID-19 treatment options and CDC’s Flu Treatment page for more information on influenza treatment options.

This dataset identifies sites that have commercially purchased inventory of COVID-19 and influenza treatments and, in some cases, may identify sites that have remaining, no-cost U.S. government distributed supply. Some sites may charge for services which may or may not be covered by insurance. Some sites may offer prescribing services for patients, including telehealth services. This dataset is intended for informational purposes only and does not serve as an endorsement or recommendation for use of any of the locations listed on the sites.

The following dashboards provide data on contagious respiratory viruses, including acute respiratory diseases, COVID-19, influenza (flu), and respiratory syncytial virus (RSV) in Massachusetts. The data presented here can help track trends in respiratory disease and vaccination activity across Massachusetts.

View daily updates and historical trends for Maine Coronavirus Tests Administered. Source: US Department of Health & Human Services. Track economic data w…

Context

The files provided are daily datasets that I scraped from the COVID-19 tracking website Worldometer over the course of 3 days—08/04/21–08/06/21. The dates don't necessarily have to contain the most recent data because that is not the intent of this dataset.

Inspiration

For me, I find making data visualizations very satisfying. Seeing a neat and tidy graph come out of an enormous CSV file is very inspirational to me. The goal is simply to use this data to make visualizations of how COVID-19 is continuing to affect each country throughout the world.

The Data

I made a pandas DataFrame out of the table on the website, and I included all 21 of their columns. Descriptions for each column are provided below.

• Country: String. Name of each country.
• TotalCases: Integer. Total number of cases
• NewCases: Integer. Number of new additional cases
• TotalDeaths: Integer. Total number of deaths due to COVID-19
• NewDeaths: Integer. Number of new additional deaths
• TotalRecovered: Integer. Total number of patients recovered from COVID-19
• NewRecovered: Integer. Number of new additional recovered patients
• ActiveCases: Integer. Number of current active cases
• Critical: Integer. Number of critically ill patients
• Tot Cases/1M pop: Integer. Total cases per 1M (one million) population
• Deaths/1M pop: Float. Deaths per 1M population
• TotalTests: Integer Total number of COVID-19 tests administered
• Tests/1M pop: String. Tests per 1M population
• Population: Integer. Population of country
• Continent: String. Continent on which the country is located
• 1 Case Every X ppl: Integer. Gives us an idea of the rate of cases per country
• 1 Death Every X ppl: Integer. Gives us an idea of the rate of death due to COVID-19
• 1 Test Every X ppl: Integer. Gives us an idea of the rate of testing per country
• New Cases/1M pop: Float. New cases per 1M population
• New Deaths/1M pop: Integer. New deaths per 1M population
• Active Cases/1M pop: Integer. Active cases per 1M population

Sources

This data was collected from https://www.worldometers.info/coronavirus/